Jacobs Levy Equity Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2018
         Q3  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2018
         Q2  | $920K | Buy | 
         | 
    |||||
| 
        
          
      
        2018
         Q1  | $144K | Sell | 
         | 
    |||||
| 
        
          
      
        2017
         Q4  | $233K | Buy | 
         | 
    |||||
| 
        
          
      
        2017
         Q3  | $225K | Buy | 
         | 
    |||||
| 
        
          
      
        2017
         Q2  | $145K | Buy | 
         | 
    |||||
| 
        
          
      
        2017
         Q1  | $135K | Sell | 
         | 
    |||||
| 
        
          
      
        2016
         Q4  | $131K | Sell | 
         | 
    |||||
| 
        
          
      
        2016
         Q3  | $344K | Sell | 
         | 
    |||||
| 
        
          
      
        2016
         Q2  | $397K | Buy | 
         | 
    |||||
| 
        
          
      
        2015
         Q4  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2015
         Q3  | $68K | Sell | 
         | 
    |||||
| 
        
          
      
        2015
         Q2  | $290K | Buy | 
         | 
    |||||
| 
        
          
      
        2015
         Q1  | $232K | Buy | 
         | 
    |||||
| 
        
          
      
        2014
         Q4  | $263K | Buy | 
         | 
    |||||
| 
        
          
      
        2014
         Q2  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2014
         Q1  | $46K | Hold | 
         | 
    |||||
| 
        
          
      
        2013
         Q4  | $26K | Sell | 
         | 
    |||||
| 
        
          
      
        2013
         Q3  | $436K | Sell | 
         | 
    |||||
| 
        
          
      
        2013
         Q2  | $991K | Buy | 
         |